Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
ASO Visual Abstract: Efficacy of Bidirectional Paclitaxel Plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single-Institution Analysis of Two Phase II Clinical Trials.
Journal: Annals of surgical oncology
Published: February 07, 2026
Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials.
Journal: Annals of surgical oncology
Published: September 24, 2025
Use of yttrium-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports.
Journal: World journal of gastroenterology
Published: September 08, 2025
Treatment of Intractable Cancer Pain with Resiniferatoxin - An Interim Study.
Journal: NEJM evidence
Published: May 27, 2025
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.
Journal: Frontiers in oncology
Published: February 14, 2024
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Journal: Journal of cancer metastasis and treatment
Published: August 04, 2023
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.
Journal: Cancers
Published: July 12, 2022
A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas.
Journal: Future oncology (London, England)
Published: May 10, 2022
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment.
Journal: Translational oncology
Published: February 24, 2022
Last Updated: 09/26/2026